By the end of the 12-week period, CBT monotherapy did not differ significantly from placebo, with each group having a CDRS-R averaging approximately 45.

• 到第12周时，CBT治疗组和安慰剂组之间就看不出有何差异，两组的CDRS-R评分都约等于45分；